Metastatic breast cancer with HER2/neu-positive cells tends to have a morbid prognosis
- 1 January 2002
- Vol. 131 (1) , S217-S221
- https://doi.org/10.1067/msy.2002.119580
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Specificity within the EGF family/ErbB receptor family signaling networkBioEssays, 1998
- Receptor Protein-Tyrosine Kinases and Their Signal Transduction PathwaysAnnual Review of Cell Biology, 1994
- Impact of axillary lymph node dissection on the therapy of breast cancer patients.Journal of Clinical Oncology, 1993
- Prognostic factors for breast cancer: have they met their promise?Journal of Clinical Oncology, 1992
- Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy gradingBritish Journal of Cancer, 1990
- Relation of tumor size, lymph node status, and survival in 24,740 breast cancer casesCancer, 1989
- Development and Use of a Natural History Data Base of Breast Cancer StudiesAmerican Journal of Clinical Oncology, 1987
- Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.Journal of Clinical Oncology, 1987
- Survival after first recurrence in breast cancerEuropean Journal of Cancer and Clinical Oncology, 1986
- The natural history of breast cancer patients with brain metastasesCancer, 1979